PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Sesquiterpenes (compounds 3, 7, 8, and 16) exhibited anti-neuroinflammatory activities in BV-2 cells [PMID:39706541]; other sesquiterpene lactones showed anti-inflammatory activity in LPS-stimulated RAW264.7 cells [PMID:38553193, PMID:35490776].
Micheliolide and parthenolide exhibit anticancer activity by inhibiting DNA biosynthesis or arresting the cell cycle [PMID:38496875, PMID:37033622]; various sesquiterpenoids showed cytotoxic activity against human cancer cell lines (e.g., MDA-MB-468, Hela) [PMID:30145456, PMID:37421692].
Extracts of M. grandiflora leaves demonstrated positive inotropic and bradycardic effects [PMID:11080935].
Evidence summary
PubMed sources
- 1.PMID: 39706541 (2025) — Anti-neuroinflammatory terpenes from Magnolia grandiflora. · Phytochemistry
- 2.PMID: 11458454 (2001) — Sesquiterpenoids from Magnolia grandiflora. · Planta medica
- 3.PMID: 36093963 (2023) — Pharmacological features, health benefits and clinical implications of honokiol. · Journal of biomolecular structure & dynamics
- 4.PMID: 38496875 (2024) — Pharmacological potential of micheliolide: A focus on anti-inflammatory and anticancer activities. · Heliyon
- 5.PMID: 2137402 (1990) — Magnolia grandiflora dermatitis. · Dermatologic clinics